Scholarlink

Objective <p>Systematically appraise the quality of clinical practice guidelines (CPGs) for vestibular schwannoma treatment and management by utilizing the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument.</p> Methods <p>A systematic search of CPGs for the treatment and management of vestibular schwannoma was conducted. MEDLINE (PubMed), EMBASE, and Scopus were queried from inception to January 2023. Inclusion criteria was national and international guidelines or consensus statements. Data was extracted from included articles and four reviewers independently evaluated guidelines in the 6 domains of the AGREE II tool. A domain score was generated with a satisfactory threshold being ≥ 60%.</p> Results <p>785 articles were screened with 9 CPGs selected for evaluation. Three CPGs were found to be “high” quality, five “average” quality, and one “low” quality. CPGs overall scored highest in the “Scope and Purpose” (domain score: 93.67 ± 7.58) and “Clarity and Presentation” (89.04 ± 13.13), while “Applicability” (40.86 ± 25.27) and “Stakeholder Involvement” (57.56 ± 22.08) had the lowest scores. The level of agreement between reviewers was high, with intraclass correlation coefficients ranging from 0.91–0.98 across domains.</p> Conclusion <p>This appraisal demonstrated an average to high quality for most CPGs regarding vestibular schwannoma treatment and management. While these findings suggest most CPGs are at least average quality, there are opportunities for improvement in several aspects, particularly in domains of applicability, clarifying of conflicts of interest, strength of methodology, and stakeholder involvement.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A systematic evaluation of clinical practice guidelines for the treatment and management of vestibular schwannoma

  • 期刊论文

  • 发表日期：

    2025年8月9日

查看全文
  • Najm S. Khan,
  • Samantha M. Shave,
  • Josephine Alegun,
  • Jonathan P. Kuriakose,
  • Phillip Ashley Wackym,
  • Scott B. Shapiro

摘要

Objective

Systematically appraise the quality of clinical practice guidelines (CPGs) for vestibular schwannoma treatment and management by utilizing the Appraisal of Guidelines for Research and Evaluation (AGREE II) instrument.

Methods

A systematic search of CPGs for the treatment and management of vestibular schwannoma was conducted. MEDLINE (PubMed), EMBASE, and Scopus were queried from inception to January 2023. Inclusion criteria was national and international guidelines or consensus statements. Data was extracted from included articles and four reviewers independently evaluated guidelines in the 6 domains of the AGREE II tool. A domain score was generated with a satisfactory threshold being ≥ 60%.

Results

785 articles were screened with 9 CPGs selected for evaluation. Three CPGs were found to be “high” quality, five “average” quality, and one “low” quality. CPGs overall scored highest in the “Scope and Purpose” (domain score: 93.67 ± 7.58) and “Clarity and Presentation” (89.04 ± 13.13), while “Applicability” (40.86 ± 25.27) and “Stakeholder Involvement” (57.56 ± 22.08) had the lowest scores. The level of agreement between reviewers was high, with intraclass correlation coefficients ranging from 0.91–0.98 across domains.

Conclusion

This appraisal demonstrated an average to high quality for most CPGs regarding vestibular schwannoma treatment and management. While these findings suggest most CPGs are at least average quality, there are opportunities for improvement in several aspects, particularly in domains of applicability, clarifying of conflicts of interest, strength of methodology, and stakeholder involvement.